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Epidermal growth factor stimulates phosphorylation of ribosomal protein S6 in serum-starved Swiss 3T3 
cells, leading to the formation of highly phosphorylated erivatives containing 4-5 phosphates. Two-dimen- 
sional analysis of tryptic phosphopeptides of S6 shows an identical pattern to the ones obtained previously 
in other cells in response to insulin and the tumor promoting phorbol ester, 12-0-tetradecanoyl phorbol- 13- 
acetate. This suggests a common intracellular mediator of S6 phosphorylation by different growth promot- 
ing agents. It is proposed that the potential mediator of this phosphorylation is the Ca2+-independent, 
CAMP-inde~ndent protein kinase, protease activated kinase II, as shown by the extent of phosphorylation 
and the tryptic phosphopeptide maps of S6 with highly purified enzyme [(1983) J. Biol. Chem. 258, 
13998-140021. 
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1. INTRODUCTION 
Ribosomal protein S6 is phospho~lated in a 
variety of cells during growth factor regulated cell 
growth and division [l-7], upon stimulation of 
cells by the phorbol ester tumor promoter, TPA 
[S-lo], as well as in malignant cell growth in viral- 
ly transformed cells deprived of serum [lo-121. 
The pathways by which all of these diverse agents 
lead to increased phosphorylation of S6 are under 
intense study. Elucidation requires isolation and 
characterization of the serine protein kinase(s) 
responsible for S6 phosphorylation under the 
various growth conditions. Although the CAMP- 
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dependent protein kinase has been shown to 
phosphorylate S6 both in vivo and in vitro 
[ 13- 161, it does not appear to be responsible for S6 
phosphorylation in growth-stimulated cells 
[5,17-201. 
Several groups have reported increased protein 
kinase activity for S6 in the soluble fraction of cell 
extracts from cells treated with growth factors 
[5,7,20]. The active form has been partially 
purified from insulin-treated 3T3-Ll preadipo- 
cytes by Perisic and Traugh [S]. Another approach 
in elucidating regulation of the protein kinase is by 
isolation of the inactive, proenzyme form and in- 
vestigation of possible modes of activation in 
vitro. Such an enzyme, denoted as protease ac- 
tivated kinase II (PAK II), has been isolated from 
rabbit reticulocytes 1211 and 3T3-Ll preadipocytes 
15). The inactive proenzyme form of PAK II is ac- 
tivated in vitro by limited proteolysis and 
phosphorylates the same sites on S6 that are 
phosphorylated in cultured cells stimulated with 
insulin [5,9] or with TPA 191. A similar pro- 
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teolytically activated enzyme, called H4 protein 
kinase, has been isolated from lymphoid cells in in- 
active form [22]. Here, we report that the EGF- 
stimulated phosphorylation of S6 is mediated by 
PAK II as shown by the extent of phosphorylation 
and phosphopeptide mapping. 
2. MATERIALS AND METHODS 
2.1. Materials 
Carrier-free [32P]orthophosphate was obtained 
from ICN, mouse EGF (culture grade) from Col- 
laborative Research and Swiss 3T3 mouse embryo 
fibroblasts from American Type Culture Collec- 
tion. Trypsin (DPCC treated) was from Sigma and 
thin-layer cellulose sheets from Eastman-Kodak. 
2.2. Phosphorylation and analysis of ribosomal 
protein S6 in Swiss 3T3 cells 
Swiss 3T3 cells were grown in Dulbecco’s 
modified Eagle’s medium containing 10% fetal 
bovine serum, in six 175 cm2 tissue culture flasks. 
At approx. 85% confluency, cells were rinsed twice 
with serum-free, phosphate-free medium at 37°C 
and incubated in the same medium for 1 h. Cells 
were then radioactively labeled in the medium sup- 
plemented with [32P]orthophosphate (0.1 mCi/ml) 
for 2 h. During the last hour of labeling, to one- 
half of the culture flasks, EGF (lo-* M) was 
added. Following incubation, cells from control 
and EGF-treated cultures were collected, lysed and 
the ribosomes prepared as described previously [5]. 
Ribosomes from Swiss 3T3 cells (0.045 mg) were 
mixed with nonlabeled carrier ribosomes from rab- 
bit reticulocytes (0.20 mg) and total ribosomal 
protein was extracted and analyzed by 
2-dimensional polyacrylamide gel electrophoresis 
as described [18]. 
2.3. Phosphopeptide mapping of ribosomal 
protein S6 
32P-labeled S6 was excised from the gel and 
digested extensively with trypsin as described [S]. 
Two-dimensional phosphopeptide mapping, with 
electrophoresis in the first dimension followed by 
ascending chromatography, was carried out ac- 
cording to Traugh et al. [14] and the phosphopep- 
tides were detected by autoradiography. 
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3. RESULTS 
Phosphorylation of ribosomal protein S6 in 
Swiss 3T3 cells, serum-starved or stimulated by 
EGF, was analyzed by 2-dimensional polyacryl- 
amide gel electrophoresis and 2-dimensional phos- 
phopeptide mapping. Swiss 3T3 cells were serum- 
starved for 1 h then labeled with 3zP for 2 h. Little 
c * 
t 
Fig. 1. Two-dimensional gel electrophoresis of ribosomal 
proteins from serum-starved and EGF-treated Swiss 3T3 
cells. Swiss 3T3 cells deprived of serum were labeled with 
[‘*P]orthophosphate in the absence (B) or presence of 
lo-* M EGF (C). A represents the stained protein 
pattern and B and C are autoradiograms. Arrows 
indicate ribosomal protein S6; numbers indicate the state 
of phosphorylation. 
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incorporation of radioactive phosphate into 
ribosomal protein S6 was observed under these 
conditions (fig. l), although other cellular proteins 
were highly phosphorylated. If, during the last 
hour of incubation, EGF (IO-’ M) was added to 
the medium, a selective enhancement of slowly 
migrating derivatives of S6 containing 4-5 phos- 
phates was observed. Thus, EGF stimulated incor- 
poration of total phosphate into S6 with an ac- 
cumulation of highly phosphorylated derivatives 
of the protein. 
The site specificity of S6 phosphorylation in- 
duced by EGF was analyzed by 2-dimensional 
phosphopeptide mapping on thin-layer cellulose 
sheets. Fig.2 shows the tryptic phospho~ptide 
pattern of S6 labeled with [32P]orthophosphate in
Swiss 3T3 cells stimulated with EGF. The complex 
pattern of tryptic phosphopeptides is identical to 
that obtained previously with S6 phosphorylated in 
3T3-Ll cells stimulated with insulin [S] and in 
Reuber H35 cells stimulated with insulin and/or 
TPA [9], with the exception that a small amount of 
phosphate is observed in peptide B. The pattern 
observed in Swiss 3T3 cells following stimulation 
with EGF contains the same phosphopeptides as 
those from 40 S ribosomal subunits phosphory- 
IO-@M EGF SCHEMATIC 
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Fig.2. Comparison of phosphopeptide patterns of S6 
phosphorylated in Swiss 3T3 cells stimulated by EGF 
with previously determined maps. An autoradiogram of 
the tryptic phosphopeptide map of S6 from serum- 
starved Swiss 3T3 cells incubated for 1 h with EGF is 
shown on the left. The schematic on the right identifies 
the tryptic phosphopeptides: crosshatching, obtained 
with 40 S ribosomal subunits and PAK II in vitro [5,18]; 
open, obtained with the CAMP-dependent protein kinase 
[13,14]; solid lines, observed both in cultured cells and 
in vitro; dotted lines, peptides detected in 3T3-Ll cells 
stimulated with insulin f5I and Reuber H35 ceils 
stimulated with insubn and/or TPA 191. 
lated with purified PAK II from rabbit reticulo- 
cytes and insulin-stimulated 3T3-Ll cells [5,22). 
Thus, it appears that PAK II is activated in 
response to EGF with the concomitant stimulation 
of phosphorylation of 56 as shown by phospho- 
peptide mapping. 
4. DISCUSSION 
In this study, we have characterized the extent 
and site specificity of the phosphorylation of 
ribosomal protein S6 in Swiss 3T3 cells stimulated 
by EGF. We compared these data with those ob- 
tained with other growth-promoting stimuli, in- 
sulin in 3T3-Ll cells [S] and TPA and/or insu~n in 
Reuber H35 hepatoma cells [9]. All of these agents 
induce the same, maximal degree of 56 
phosphorylation and lead to phosphorylation of 
the same sites on S6, as shown by 2-dimensional 
analysis of tryptic digests of 32P-labeIed S6. The 
same basic phosphopeptide pattern is also ob- 
served in vitro when 40 S ribosomal subunits are 
phosphorylated with PAK II [18]. These data sug- 
gest that PAK II is responsible for the EGF- 
stimulated phosphorylation of S6 in Swiss 3T3 
cells and is activated in response to the hormone. 
A small amount of phosphate is also observed in 
peptide B. This phosphopeptide is not detected in 
S6 from other cell types stimulated with insulin or 
TPA [5,9] or in vitro with purified PAK II 1181. 
Peptide B has previously been shown to contain 
sites phosphorylated by the CAMP-dependent pro- 
tein kinase [13,14], Martin-Perez et al. (191 have 
also identified a small amount of phosphorylation 
of S6 in response to EGF which is attributable to 
the CAMP-dependent protein kinase. This suggests 
that Swiss 3T3 cells may contain higher levels of 
cAMP and/or CAMP-dependent protein kinase or 
that the CAMP-dependent protein kinase may be 
involved in partially mediating EGF action. 
PAK II is isolated from the postribosomal 
supernatant fraction of rabbit reticulocytes in an 
inactive form, and is activated in vitro by limited 
proteolysis [21], or by dia~ylglycerol and 
phosphatidylserine in a Ca2+-independent manner 
1231. We have shown previously that the enzyme is 
present as an inactive proenzyme in serum-starved 
3T3-Ll cells and is rapidly activated upon addition 
of insulin to the cells. The activated form of the en- 
zyme is separable from the inactive form by ion- 
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exchange chromatography, cannot be activated 
further by limited proteolysis, and the activity is 
expressed in the absence of Ca2+ or phospholipids 
151. 
Recent reports indicate that the same sites on S6 
are phosphorylated not only during the normal 
growth processes regulated by different growth 
factors [7,9], but also in serum-deprived cells 
transformed by retroviruses [10,12]. All of these 
data suggest a unique serine protein kinase that 
acts as a common intracellular mediator of 
growth-promoting agents. From our studies, this 
protein kinase has been identified as PAK II. 
Mechanism(s) which regulate the activity of 
PAK II in vivo are unknown. A common feature 
in the action of both growth factors and trans- 
forming RNA viruses is the activation of tyrosine- 
specific protein kinases [24-301. These protein 
kinases could regulate the activity of S6 kinase 
through phosphorylation. This idea is supported 
by the finding that the presence of phosphatase in- 
hibitors during cell extraction is crucial in ob- 
taining the fully active form of the S6 kinase in 
serum or EGF-induced Swiss 3T3 cells [20]. Our 
recent investigations show phosphorylation of a 
protein in the PAK II preparation on tyrosine with 
the concomitant activation of PAK II by three dif- 
ferent tyrosine-specific protein kinases, the EGF 
receptor, the insulin receptor and Abelson kinase 
(in preparation). Nevertheless, this and other alter- 
native modes of activation need further investiga- 
tion before all possible physiological modes of ac- 
tivation for the enzyme are determined. 
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